FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Patrick Vermersch

Research Profile

Disorders

Concepts & Ideas

Anatomy

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Ludwig Kappos; Paul W O'Connor; Amy Pace; Christopher H Polman; Patrick Vermersch; Heinz Wiendl; Annie Zhang; Christophe Hotermans
Clinical effects of natalizumab on multiple sclerosis appear early in treatment course.
Giancarlo Comi; Stuart D Cook; Gavin Giovannoni; Anthony C Hamlett; Kottil W. Rammohan; Peter Rieckmann; Per Soelberg Sørensen; Patrick Vermersch; Vissia Viglietta; Steven J Greenberg
MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study.
Jean-Baptiste Chanson; Laurent Ballonzoli; Frédéric Blanc; Andoni Echaniz-Laguna; Stéphane Kremer; Arnaud Lacour; Béatrice Lannes; Izzie-Jacques Namer; Christine Tranchant; Patrick Vermersch; Jérôme de Seze
Central nervous system abnormalities in patients with PMP22 gene mutations: a prospective study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Patrick Vermersch (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ludwig Kappos; Paul W O'Connor; Amy Pace; Christopher H Polman; Patrick Vermersch; Heinz Wiendl; Annie Zhang; Christophe Hotermans
Clinical effects of natalizumab on multiple sclerosis appear early in treatment course.
Journal of neurology 2013;260(5):1388-95.
2013: Giancarlo Comi; Stuart D Cook; Gavin Giovannoni; Anthony C Hamlett; Kottil W. Rammohan; Peter Rieckmann; Per Soelberg Sørensen; Patrick Vermersch; Vissia Viglietta; Steven J Greenberg
MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study.
Journal of neurology 2013;260(4):1136-46.
2013: Jean-Baptiste Chanson; Laurent Ballonzoli; Frédéric Blanc; Andoni Echaniz-Laguna; Stéphane Kremer; Arnaud Lacour; Béatrice Lannes; Izzie-Jacques Namer; Christine Tranchant; Patrick Vermersch; Jérôme de Seze
Central nervous system abnormalities in patients with PMP22 gene mutations: a prospective study.
Journal of neurology, neurosurgery, and psychiatry 2013;84(4):392-7.
2013: Nicolas Collongues; Patrick Vermersch
Multiple sclerosis spasticity: 'state-of-the-art' questionnaire survey of specialized healthcare professionals.
Expert review of neurotherapeutics 2013;13(3 Suppl 1):21-5.
2012: Nicolas Collongues; Jérôme de Seze; Arnaud Lacour; Christine Tranchant; Patrick Vermersch; Olivier Casez; Christine Lebrun
Rituximab in refractory and non-refractory myasthenia: a retrospective multicenter study.
Muscle & nerve 2012;46(5):687-91.
2012: Olivier Outteryck; Patrick Vermersch; Hélène Zéphir; Anne-Sophie Berteloot; F Blanc; Nicolas Collongues; Alain Duhamel; MC Fleury; Marianne Giroux; Arnaud Lacour; Jean Claude Ongagna; J de Sèze
Anti-JCV antibody prevalence in a French cohort of MS patients under natalizumab therapy.
Journal of neurology 2012;259(11):2293-8.
2012: R Dassé; Sylvain Dubucquoi; Patricia Dussart; V Dutoit-Lefèvre; Didier Lefranc; Boualem Sendid; F Sombo Mambo; Patrick Vermersch; Lionel Prin
[Singular, systemic, self-reactive IgG patterns related to age: relationship with cerebral malaria susceptibility in exposed subjects residing in an endemic area in Abidjan, Côte-d'Ivoire].
Bulletin de la Société de pathologie exotique (1990) 2012;105(4):276-83.
2012: Rémy Phan-Ba; Christian Sindic; Shibeshih Belachew; Gustave Moonen; Olivier Outteryck; Mathieu Vokaer; Patrick Vermersch
The earlier, the smaller, the better for natalizumab-associated PML: in MRI vigilance veritas?
Neurology 2012;79(10):1067-9.
2012: Olivier Outteryck; Tanya Stojkovic; Hélène Zéphir; Marilyn Cabaret; Jean-Marie Cuisset; J de Sèze; Sophie Delalande; Vincent Deramecourt; Dries Dobbelaere; Brian Fowler; Arnaud Lacour; Anne-Catherine Lepoutre; Patrick Vermersch
Methionine synthase deficiency: a rare cause of adult-onset leukoencephalopathy.
Neurology 2012;79(4):386-8.
2012: Jérôme Hodel; Olivier Outteryck; Mathieu Rodallec; Patrick Vermersch; Hélène Zéphir; Marc Zins; Xavier Leclerc
Cranial nerve involvement in infratentorial progressive multifocal leukoencephalopathy.
Neurology 2012;79(1):104-5.
2012: A Melin; Jean Claude Ongagna; O Outteryck; Patrick Vermersch; Hélène Zéphir; A S Berteloot; F Blanc; N Collongues; MC Fleury; A Lacour; J de Sèze
Effect of natalizumab on clinical and radiological disease activity in a French cohort of patients with relapsing-remitting multiple sclerosis.
Journal of neurology 2012;259(6):1215-21.
2012: B Bourre; David Brassat; Giovanni Castelnovo; N Collongues; Christian Confavreux; Jérôme de Seze; Bertrand Fontaine; Pierre Labauge; R Marignier; O Outteryck; Caroline Papeix; Patrick Vermersch; Sandra Vukusic; Hélène Zéphir
Neuromyelitis optica and pregnancy.
Neurology 2012;78(12):875-9.
2012: Bertrand Bourre; Nicolas Collongues; Charlotte Cordonnier; Stephanie Debette; Marie-Celine Fleury; Didier Hannequin; Jean Claude Ongagna; Olivier Outerryck; Patrick Vermersch; Hélène Zéphir; Olivier Outteryck; Jérôme de Seze
Long-term follow-up of acute partial transverse myelitis.
Archives of neurology 2012;69(3):357-62.
2012: Patrick Vermersch; Cyrille Vongsouthi; Hélène Zéphir; Alain Moussy; Nicolas Schmidt; Rabah Benrabah; Pierre Clavelou; Patrice Dubreuil; Olivier Hermine
Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study.
BMC neurology 2012;12():36.
2012: Shehzad Ali; Giancarlo Comi; Stuart Cook; Gavin Giovannoni; Steven Greenberg; Alexandre Joyeux; Noman Paracha; Kottil W. Rammohan; Peter Rieckmann; David A Scott; Per Soelberg Sørensen; Patrick Vermersch
Reduction in healthcare and societal resource utilization associated with cladribine tablets in patients with relapsing-remitting multiple sclerosis: analysis of economic data from the CLARITY Study.
Clinical drug investigation 2012;32(1):15-27.
2012: R Le Bouc; B Majed; M Marcel; A Vérier; Hélène Zéphir; Patrick Vermersch
No increase in cancer incidence detected after cyclophosphamide in a French cohort of patients with progressive multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2012;18(1):55-63.
2011: Nicolas Collongues; Christian Confavreux; Jérôme de Seze; Bertrand Fontaine; Christine Lebrun-Frenay; Romain Marignier; Caroline Papeix; Jean Pelletier; Patrick Vermersch; Hélène Zéphir; Bertrand Audoin; Philippe Cabre
A benign form of neuromyelitis optica: does it exist?
Archives of neurology 2011;68(7):918-24.
2011: Christine Lebrun; Lucien Rumbach; Ayman Tourbah; Patrick Vermersch; Sandrine Wiertlevsky; David Brassat; Pierre Clavelou; Jérôme de Seze; Marc Debouverie; Gilles Defer; Agnes Fromont; Olivier Heinzlef; Marc Frenay
Cancer and multiple sclerosis in the era of disease-modifying treatments.
Journal of neurology 2011;258(7):1304-11.
2011: N Collongues; Christian Confavreux; Marc Debouverie; G Defer; N Derache; M Fleury; O Gout; Pierre Labauge; R Marignier; T Moreau; O Outteryck; J Pelletier; A Ruet; E Thouvenot; Patrick Vermersch; Sandra Vukusic; Hélène Zéphir; B Audoin; F Blanc; F Borgel; David Brassat; Bruno Brochet; William Camu; J de Seze
High-risk syndrome for neuromyelitis optica: a descriptive and comparative study.
Multiple sclerosis (Houndmills, Basingstoke, England) 2011;17(6):720-4.
2011: J-B Chanson; Hélène Zéphir; N Collongues; O Outteryck; F Blanc; M Fleury; Patrick Vermersch; Jérôme de Seze
Evaluation of health-related quality of life, fatigue and depression in neuromyelitis optica.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2011;18(6):836-41.
2011: Gavin Giovannoni; Stuart Cook; Kottil W. Rammohan; Peter Rieckmann; Per Soelberg Sørensen; Patrick Vermersch; Anthony Hamlett; Vissia Viglietta; Steven Greenberg
Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis.
Lancet neurology 2011;10(4):329-37.
2011: Catalina Lee-Chang; Isabelle Top; Hélène Zéphir; Sylvain Dubucquoi; Jacques Trauet; Patricia Dussart; Lionel Prin; Patrick Vermersch
Primed status of transitional B cells associated with their presence in the cerebrospinal fluid in early phases of multiple sclerosis.
Clinical immunology (Orlando, Fla.) 2011;139(1):12-20.
2011: Catalina Lee-Chang; Didier Lefranc; Julia Salleron; Christelle Faveeuw; Cecile Allet; Patrick Vermersch; Bénédicte Oxombre; Lionel Prin
Susceptibility to experimental autoimmune encephalomyelitis is associated with altered B-cell subsets distribution and decreased serum BAFF levels.
Immunology letters 2011;135(1-2):108-17.
2011: Hans-Peter Hartung; Xavier Montalban; Per Soelberg Sorensen; Patrick Vermersch; Tomas Olsson
Principles of a new treatment algorithm in multiple sclerosis.
Expert review of neurotherapeutics 2011;11(3):351-62.
2011: Olivier Simon; Arnaud Lacour; Arnaud DELVAL; Anne Beaume; Patrick Vermersch
Recurrent multiple cranial nerve palsy and anti-GD1a antibodies.
Muscle & nerve 2011;43(3):447-8.
2011: Bernard Puech; Arnaud Lacour; Giovanni Stevanin; Bruno G Sautiere; David Devos; Christel Depienne; Elodie Denis; Emeline Mundwiller; Didier Ferriby; Patrick Vermersch; Sabine Defoort-Dhellemmes
Kjellin syndrome: long-term neuro-ophthalmologic follow-up and novel mutations in the SPG11 gene.
Ophthalmology 2011;118(3):564-73.
2011: Catalina Lee-Chang; Hélène Zéphir; Isabelle Top; Sylvain Dubucquoi; Jacques Trauet; Lionel Prin; Patrick Vermersch
B-cell subsets up-regulate α4 integrin and accumulate in the cerebrospinal fluid in clinically isolated syndrome suggestive of multiple sclerosis onset.
Neuroscience letters 2011;487(3):273-7.
2011: Romuald Dassé; Sylvain Dubucquoi; Patricia Dussart; Virginie Dutoit-Lefevre; Didier Lefranc; Boualem Sendid; François Sombo Mambo; Patrick Vermersch; Lionel Prin
Changes Related to Age in Natural and Acquired Systemic Self-IgG Responses in Malaria.
Interdisciplinary perspectives on infectious diseases 2011;2011():462767.
2010: Adrian Degardin; David Morillon; Arnaud Lacour; Anne Cotten; Patrick Vermersch; Tanya Stojkovic
Morphologic imaging in muscular dystrophies and inflammatory myopathies.
Skeletal radiology 2010;39(12):1219-27.
2010: Olivier Outteryck; David Devos; Patrice Jissendi; Odile Boespflug-Tanguy; Lucie Hopes; Dimitri Renard; Joël Ferri; Patrick Vermersch; Pierre Labauge
4H syndrome: a rare cause of leukodystrophy.
Journal of neurology 2010;257(10):1759-61.
2010: N Collongues; R Marignier; H Zéphir; C Papeix; B Fontaine; F Blanc; D Rodriguez; M Fleury; S Vukusic; J Pelletier; B Audoin; E Thouvenot; William Camu; B Barroso; A Ruet; B Brochet; Patrick Vermersch; Christian Confavreux; Jérôme de Seze
Long-term follow-up of neuromyelitis optica with a pediatric onset.
Neurology 2010;75(12):1084-8.
2010: dimitri renard; Giovanni Castelnovo; Philippe Jean Bousquet; Nicolas de Champfleur; Jérôme de Seze; Patrick Vermersch; Pierre Labauge
Brain MRI findings in long-standing and disabling multiple sclerosis in 84 patients.
Clinical neurology and neurosurgery 2010;112(4):286-90.
2010: Gavin Giovannoni; Giancarlo Comi; Stuart Cook; Kottil W. Rammohan; Peter Rieckmann; Per Soelberg Sørensen; Patrick Vermersch; Peter Chang; Anthony Hamlett; Bruno Musch; Steven J Greenberg
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.
The New England journal of medicine 2010;362(5):416-26.
2010: Olivier Outteryck; J-C Ongagna; Hélène Zéphir; M-C Fleury; A Lacour; F Blanc; Patrick Vermersch; J de Sèze
Demographic and clinic characteristics of French patients treated with natalizumab in clinical practice.
Journal of neurology 2010;257(2):207-11.
2010: Gauthier Calais; G Forzy; Charlotte Crinquette; Alexandre Mackowiak; Jérôme de Seze; Frederic Blanc; Christine Lebrun; Olivier Heinzlef; Pierre Clavelou; Thibault Moreau; Bernadette Hennache; Helene Zephir; Albert Verier; Véronique Neuville; Christian Confavreux; Patrick Vermersch; P Hautecoeur
Tear analysis in clinically isolated syndrome as new multiple sclerosis criterion.
Multiple sclerosis (Houndmills, Basingstoke, England) 2010;16(1):87-92.
2009: Guillaume Lefèvre; Viviane Queyrel; Claude-Alain Maurage; Charles Laurent; David Launay; Arnaud Lacour; Hilaire Charlanne; Sandrine Morell-Dubois; Marc Lambert; Hélène Maillard; Patrick Vermersch; Eric Hachulla; Pierre-Yves Hatron
Effective immune restoration after immunosuppressant discontinuation in a lupus patient presenting progressive multifocal leukoencephalopathy.
Journal of the neurological sciences 2009;287(1-2):246-9.
2009: Hélène Bourteel; Patrick Vermersch; Jean-Marie Cuisset; Claude-Alain Maurage; P Laforet; P Richard; Tanya Stojkovic
Clinical and mutational spectrum of limb-girdle muscular dystrophy type 2I in 11 French patients.
Journal of neurology, neurosurgery, and psychiatry 2009;80(12):1405-8.
2009: Olivier Outteryck; Hélène Zephir; Sabine Defoort; Marie Bouyon; Philippe Debruyne; Ikram Bouacha; Didier Ferriby; Arnaud Lacour; Pierre Labalette; Jérôme de Seze; Patrick Vermersch
Optical coherence tomography in clinically isolated syndrome: no evidence of subclinical retinal axonal loss.
Archives of neurology 2009;66(11):1373-7.
2009: Stéphanie Debette; J de Sèze; Jean-Pierre Pruvo; H Zephir; Florence Pasquier; Didier LEYS; Patrick Vermersch
Long-term outcome of acute and subacute myelopathies.
Journal of neurology 2009;256(6):980-8.
2009: Bilal Majed; Hélène Zephir; Valérie Pichonnier-Cassagne; Yazdan Yazdanpanah; Philippe Lestavel; Pierre Valette; Patrick Vermersch
Lumbar punctures: use and diagnostic efficiency in emergency medical departments.
International journal of emergency medicine 2009;2(4):227-35.
2009: Hélène Zéphir; Tanya Stojkovic; Jérôme de Seze; Claude-Alain Maurage; Katell Peoc'h; Stéphane Haïk; Patrick Vermersch
Severe and rapidly evolving peripheral neuropathy revealing sporadic Creutzfeldt-Jakob disease.
Journal of neurology 2009;256(1):134-6.
2008: H Zéphir; Tanya Stojkovic; P Latour; A Lacour; Jérôme de Seze; O Outteryck; Claude-Alain Maurage; C Monpeurt; P Chatelet; E Ovelacq; Patrick Vermersch
Relapsing demyelinating disease affecting both the central and peripheral nervous systems.
Journal of neurology, neurosurgery, and psychiatry 2008;79(9):1032-9.
2008: Jérôme de Seze; Frederic Blanc; Luc Jeanjean; Hélène Zéphir; Pierre Labauge; Marie Bouyon; Laurent Ballonzoli; Giovanni Castelnovo; Marie Fleury; Sabine Defoort; Patrick Vermersch; Claude Speeg
Optical coherence tomography in neuromyelitis optica.
Archives of neurology 2008;65(7):920-3.
2008: Jérôme de Seze; C Arndt; L Jeanjean; H Zephir; F Blanc; Pierre Labauge; M Bouyon; L Ballonzoli; M Fleury; Patrick Vermersch; C Speeg
Relapsing inflammatory optic neuritis: is it neuromyelitis optica?
Neurology 2008;70(22):2075-6.
2008: Catherine Massart; Jacqueline Gibassier; Jérôme de Seze; Marc Debouverie; Thibault Moreau; Jean Pelletier; Patrick Vermersch; Gilles Edan
Determination of interferon beta neutralizing antibodies in multiple sclerosis: improvement of clinical sensitivity of a cytopathic effect assay.
Clinica chimica acta; international journal of clinical chemistry 2008;391(1-2):98-101.
2008: Romain Marignier; Jérôme De Sèze; Sandra Vukusic; Françoise Durand-Dubief; Hélène Zéphir; Patrick Vermersch; Philippe Cabre; Gaëlle Cavillon; Jérôme Honnorat; Christian Confavreux
NMO-IgG and Devic's neuromyelitis optica: a French experience.
Multiple sclerosis (Houndmills, Basingstoke, England) 2008;14(4):440-5.
2008: Christine Lebrun; Marc Debouverie; Patrick Vermersch; Pierre Clavelou; Lucien Rumbach; Jérôme de Seze; Sandrine Wiertlevski; Gilles Defer; Olivier Gout; Frédéric Berthier; Arlette Danzon
Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2008;14(3):399-405.
2008: Marc Bitoun; Tanya Stojkovic; Bernard Prudhon; Claude-Alain Maurage; Philippe Latour; Patrick Vermersch; Pascale Guicheney
A novel mutation in the dynamin 2 gene in a Charcot-Marie-Tooth type 2 patient: clinical and pathological findings.
Neuromuscular disorders : NMD 2008;18(4):334-8.
2008: C M Dhaenens; Susanna Schraen-Maschke; H Tran; V Vingtdeux; D Ghanem; O Leroy; J Delplanque; E Vanbrussel; André Delacourte; Patrick Vermersch; Claude-Alain Maurage; Gruffat Henri; A Sergeant; M S Mahadevan; S Ishiura; Luc BUEE; T A Cooper; Marie-Laure Caillet-Boudin; N Charlet-Berguerand; B Sablonnière; N Sergeant
Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats.
Experimental neurology 2008;210(2):467-78.
2008: Frédéric Blanc; Hélène Zéphir; Christine Lebrun; Pierre Labauge; Giovanni Castelnovo; Marie Fleury; François Sellal; Christine Tranchant; Kathy Dujardin; Patrick Vermersch; Jérôme de Seze
Cognitive functions in neuromyelitis optica.
Archives of neurology 2008;65(1):84-8.
2008: Sean J Pittock; Vanda A Lennon; Jérôme de Seze; Patrick Vermersch; Henry A Homburger; Dean M Wingerchuk; Claudia F Lucchinetti; Hélène Zéphir; Kevin G Moder; Brian G Weinshenker
Neuromyelitis optica and non organ-specific autoimmunity.
Archives of neurology 2008;65(1):78-83.
2007: C Crinquette; Jérôme de Seze; Claude-Alain Maurage; D Launay; Didier Ferriby; Sophie Delalande; Eric Hachulla; Tanya Stojkovic; Patrick Vermersch
[Polymyositis and cranial neuropathy].
Revue neurologique 2007;163(11):1075-81.
2007: Thomas P Leist; Patrick Vermersch
The potential role for cladribine in the treatment of multiple sclerosis: clinical experience and development of an oral tablet formulation.
Current medical research and opinion 2007;23(11):2667-76.
2007: Jérôme de Seze; Marc Debouverie; Hélène Zephir; Christine Lebrun; Frédéric Blanc; Véronique Bourg; Sandrine Wiertlewski; Sophie Pittion; David Laplaud; Emmanuelle Le Page; Romain Deschamps; Philippe Cabre; Jean Pelletier; Irina Malikova; Pierre Clavelou; Valérie Jaillon; Gilles Defer; Pierre Labauge; Olivier Gout; Clotilde Boulay; Gilles Edan; Patrick Vermersch
Acute fulminant demyelinating disease: a descriptive study of 60 patients.
Archives of neurology 2007;64(10):1426-32.
2007: Didier Lefranc; David Launay; Sylvain Dubucquoi; Jérôme de Seze; Patricia Dussart; Marie Vermersch; Eric Hachulla; Pierre-Yves Hatron; Patrick Vermersch; Luc Mouthon; Lionel Prin
Characterization of discriminant human brain antigenic targets in neuropsychiatric systemic lupus erythematosus using an immunoproteomic approach.
Arthritis and rheumatism 2007;56(10):3420-32.
2007: Christel Renoux; Sandra Vukusic; Yann Mikaeloff; Gilles Edan; Michel Clanet; Bénédicte Dubois; Marc Debouverie; Bruno Brochet; Christine Lebrun-Frenay; Jean Pelletier; Thibault Moreau; Catherine Lubetzki; Patrick Vermersch; Etienne Roullet; Laurent Magy; Marc Tardieu; Samy Suissa; Christian Confavreux
Natural history of multiple sclerosis with childhood onset.
The New England journal of medicine 2007;356(25):2603-13.
2007: Jérôme de Seze; Marc Debouverie; N Waucquier; G Steinmetz; Sophie Pittion; Hélène Zephir; M Fleury; F Blanc; Patrick Vermersch
Primary progressive multiple sclerosis: a comparative study of the diagnostic criteria.
Multiple sclerosis (Houndmills, Basingstoke, England) 2007;13(5):622-5.
2007: Stephan Klebe; Arnaud Lacour; Alexandra Durr; Tanya Stojkovic; Christel Depienne; Sylvie Forlani; Sandrine Poea-Guyon; Isabelle Vuillaume; Bernard Sablonniere; Patrick Vermersch; Alexis Brice; Giovanni Stevanin
NIPA1 (SPG6) mutations are a rare cause of autosomal dominant spastic paraplegia in Europe.
Neurogenetics 2007;8(2):155-7.
2007: Caroline Papeix; Jean-Sébastien Vidal; Jérôme de Seze; Charles Pierrot-Deseilligny; Ayman Tourbah; Bruno Stankoff; Christine Lebrun; Thibault Moreau; Patrick Vermersch; Bertrand Fontaine; Olivier Lyon-Caen; Olivier Gout
Immunosuppressive therapy is more effective than interferon in neuromyelitis optica.
Multiple sclerosis (Houndmills, Basingstoke, England) 2007;13(2):256-9.
2007: Hélène Bourteel; Tanya Stojkovic; Jean-Marie Cuisset; Claude-Alain Maurage; P Laforet; P Richard; Patrick Vermersch
[Phenotypic aspects of FKRP-linked muscular dystrophy type 2I in a series of eleven patients].
Revue neurologique 2007;163(2):189-96.
2007: Olivier Outteryck; Tanya Stojkovic; David Launay; Brigitte Meignie-Ramon; Patrick Vermersch
Periorbital ecchymoses are not pathognomonic of the light-chain type of amyloidosis.
Acta dermato-venereologica 2007;87(6):544-5.
2007: Christine Lebrun; Marc Debouverie; Patrick Vermersch; Pierre Clavelou; Lucien Rumbach; Jérôme de Seze; Gilles Defer; F Berthier
[CARIMS (Cancer Risk In Multiple Sclerosis) project: impact of long-term treatment].
Revue neurologique 2007;163(1):38-46.
2007: Patrick Vermersch; N Waucquier; Emmanuel Michelin; Hélène Bourteel; Tanya Stojkovic; Didier Ferriby; Jérôme de Seze
Combination of IFN beta-1a (Avonex) and mycophenolate mofetil (Cellcept) in multiple sclerosis.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2007;14(1):85-9.
2007: Mohamed El-Behi; Hélène Zéphir; Didier Lefranc; Virginie Dutoit; Patricia Dussart; Patrick Devos; Jean-Paul Dessaint; Patrick Vermersch; Lionel Prin
Changes in self-reactive IgG antibody repertoire after treatment of experimental autoimmune encephalomyelitis with anti-allergic drugs.
Journal of neuroimmunology 2007;182(1-2):80-8.
2006: Jérôme de Seze; Hélène Zephir; P Hautecoeur; A Mackowiak; Marilyn Cabaret; Patrick Vermersch
Pathologic laughing and intractable hiccups can occur early in multiple sclerosis.
Neurology 2006;67(9):1684-6.
2006: Patrick Vermersch
Editorial: the pitfalls of combination therapy.
International MS journal / MS Forum 2006;13(3):75-6.
2006: Hélène Zephir; Lionel Almeras; Mohamed El-Behi; Patricia Dussart; Jérôme de Seze; Jerome Steibel; Elizabeth Trifilieff; Sylvain Dubucquoi; Jean-Paul Dessaint; Patrick Vermersch; Lionel Prin; Didier Lefranc
Diversified serum IgG response involving non-myelin CNS proteins during experimental autoimmune encephalomyelitis.
Journal of neuroimmunology 2006;179(1-2):53-64.
2006: Didier Ferriby; Tanya Stojkovic; D Sternberg; Jean-François Hurtevent; J-P Hurtevent; Patrick Vermersch
A new case of autosomal dominant myotonia associated with the V1589M missense mutation in the muscle sodium channel gene and its phenotypic classification.
Neuromuscular disorders : NMD 2006;16(5):321-4.
2006: Jérôme de Seze; Sandra Vukusic; M Viallet-Marcel; Caroline Tilikete; Hélène Zéphir; Sophie Delalande; Tanya Stojkovic; S Defoort-Dhellemmes; Christian Confavreux; Patrick Vermersch
Unusual ocular motor findings in multiple sclerosis.
Journal of the neurological sciences 2006;243(1-2):91-5.
2006: Jérôme de Seze; Sophie Delalande; Anne-Laure Fauchais; Eric Hachulla; Tanya Stojkovic; Didier Ferriby; Pierre-Yves Hatron; Patrick Vermersch
Myelopathies secondary to Sjögren's syndrome: treatment with monthly intravenous cyclophosphamide associated with corticosteroids.
The Journal of rheumatology 2006;33(4):709-11.
2006: C Ramirez; Jérôme de Seze; O Delrieu; Tanya Stojkovic; Sophie Delalande; F Fourrier; Didier LEYS; Luc Defebvre; Alain Destée; Patrick Vermersch
[Myasthenia gravis and pregnancy: clinical course and management of delivery and the postpartum phase].
Revue neurologique 2006;162(3):330-8.
2006: Arnaud DELVAL; Tanya Stojkovic; Patrick Vermersch
Relapsing sensorimotor neuropathy with ophthalmoplegia, antidisialosyl antibodies, and extramembranous glomerulonephritis.
Muscle & nerve 2006;33(2):274-7.
2005: Jérôme de Seze; C Lanctin; Christine Lebrun; Irina Malikova; Caroline Papeix; Sandrine Wiertlewski; J Pelletier; Olivier Gout; C Clerc; C Moreau; Gilles Defer; Gilles Edan; Frédéric Dubas; Patrick Vermersch
Idiopathic acute transverse myelitis: application of the recent diagnostic criteria.
Neurology 2005;65(12):1950-3.
2005: Jérôme de Seze; V Canva-Delcambre; I Fajardy; Sophie Delalande; Tanya Stojkovic; E Godet; Patrick Vermersch
Autoimmune hepatitis and multiple sclerosis: a coincidental association?
Multiple sclerosis (Houndmills, Basingstoke, England) 2005;11(6):691-3.
2005: Patrick Vermersch; S Dufourd-Delalande; S Defoort-Dhellemmes; Tanya Stojkovic; D Launay; Jérôme de Seze
[Tonic pupils in Sjögren's syndrome].
Revue neurologique 2005;161(10):963-6.
2005: Jérôme de Seze; Patrick Vermersch
Sequential magnetic resonance imaging follow-up of multiple sclerosis before the clinical phase.
Multiple sclerosis (Houndmills, Basingstoke, England) 2005;11(4):395-7.
2005: Hélène Zéphir; Tanya Stojkovic; Philippe Latour; Jean-François Hurtevent; F Blankaert; Patrick Vermersch
A family with a novel frameshift mutation in the PMP22 gene (c.433_434insC) causing a phenotype of hereditary neuropathy with liability to pressure palsies.
Neuromuscular disorders : NMD 2005;15(7):493-7.
2005: Hélène Zéphir; Jérôme de Seze; Kathy Dujardin; G Dubois; Marilyn Cabaret; S Bouillaguet; Didier Ferriby; Tanya Stojkovic; Patrick Vermersch
One-year cyclophosphamide treatment combined with methylprednisolone improves cognitive dysfunction in progressive forms of multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2005;11(3):360-3.
2005: M Paulin; Jérôme de Seze; P Wyremblewski; Hélène Zéphir; Didier LEYS; Patrick Vermersch
Man-in-the-barrel syndrome caused by a pontine lesion.
Neurology 2005;64(10):1703.
2005: Sophie Delalande; J de Sèze; J-P Hurtevent; Tanya Stojkovic; Jean-François Hurtevent; Patrick Vermersch
[Cortical blindness associated with Guillain-Barre syndrome: a complication of dysautonomia?].
Revue neurologique 2005;161(4):465-7.
2005: Jérôme de Seze; Sophie Delalande; Emmanuel Michelin; Jean-Yves Gauvrit; M A Mackowiak; Didier Ferriby; Tanya Stojkovic; Luc Defebvre; Jean-Pierre Pruvo; Patrick Vermersch
Brain MRI in late-onset multiple sclerosis.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2005;12(4):241-4.
2005: Louise Tyvaert; Tanya Stojkovic; Jean-Marie Cuisset; marie T vanier; J-C Turpin; J de Sèze; Patrick Vermersch
[Presentation of Niemann-Pick type C disease with psychiatric disturbance in an adult].
Revue neurologique 2005;161(3):318-22.
2005: Mohamed El-Behi; Sylvain Dubucquoi; Didier Lefranc; Hélène Zéphir; Jérôme de Seze; Patrick Vermersch; Lionel Prin
New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis.
Immunology letters 2005;96(1):11-26.
2005: Patrick Vermersch; Tanya Stojkovic; Jérôme de Seze
Mycophenolate mofetil and neurological diseases.
Lupus 2005;14 Suppl 1():s42-5.
2004: William H Stuart; Patrick Vermersch
Concomitant therapy for multiple sclerosis.
Neurology 2004;63(11 Suppl 5):S28-34.
2004: E Le Rhun; J de Sèze; Tanya Stojkovic; Didier Ferriby; F Fourrier; Patrick Vermersch
[Guillain-Barré syndrome with hallucinations and onirism: an underestimated association].
Revue neurologique 2004;160(12):1207-10.
2004: C Ramirez; Jérôme de Seze; Sophie Delalande; Emmanuel Michelin; Didier Ferriby; A Al Khedr; Tanya Stojkovic; Alain Destée; Patrick Vermersch
[Infectious myelopathies: clinical, serological, and prognostic patterns].
Revue neurologique 2004;160(11):1048-58.
2004: Marie-Christine Vantyghem; Pascal Pigny; Claude-Alain Maurage; N Rouaix-Emery; Tanya Stojkovic; Jean-Marie Cuisset; Alain Millaire; Olivier Lascols; Patrick Vermersch; Jean-Louis Wemeau; Jacqueline Capeau; Corinne Vigouroux
Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities.
The Journal of clinical endocrinology and metabolism 2004;89(11):5337-46.
2004: C Ramirez; J de Sèze; Tanya Stojkovic; Didier Ferriby; Sophie Delalande; S Defoort-Dhellemmes; Patrick Vermersch
[Pure subacute pandysautonomia: an assessment of treatment with intravenous polyvalent immunoglobulins].
Revue neurologique 2004;160(10):939-41.
2004: Arnaud DELVAL; Tanya Stojkovic; J de Sèze; Jean-François Hurtevent; F Glowacki; A Beaume; Alain Destée; Patrick Vermersch
[Ataxic neuropathy associated with disialosylated antibodies: description of new clinical and biochemical forms].
Revue neurologique 2004;160(10):910-6.
2004: Jérôme de Seze; M Chapelotte; Sophie Delalande; Didier Ferriby; Tanya Stojkovic; Patrick Vermersch
Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(5):596-7.
2004: V Deramecourt; Jérôme de Seze; Sophie Delalande; F Cassim; Patrick Vermersch
[Multiple sclerosis with sensory disturbances and hyperhidrosis of the hand].
Revue neurologique 2004;160(8-9):830-2.
2004: Sophie Delalande; Jérôme de Seze; Anne-Laure Fauchais; Eric Hachulla; Tanya Stojkovic; Didier Ferriby; Sylvain Dubucquoi; Jean-Pierre Pruvo; Patrick Vermersch; Pierre-Yves Hatron
Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients.
Medicine 2004;83(5):280-91.
2004: A Bourahoui; Jérôme de Seze; R Guttierez; B Onraed; Bernadette Hennache; Didier Ferriby; Tanya Stojkovic; Patrick Vermersch
CSF isoelectrofocusing in a large cohort of MS and other neurological diseases.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2004;11(8):525-9.
2004: Lionel Almeras; Didier Lefranc; Hervé Drobecq; Jérôme de Seze; Sylvain Dubucquoi; Patrick Vermersch; Lionel Prin
New antigenic candidates in multiple sclerosis: identification by serological proteome analysis.
Proteomics 2004;4(7):2184-94.
2004: Tanya Stojkovic; Philippe Latour; Ghislaine Viet; Jérôme de Seze; Jean-François Hurtevent; Antoon Vandenberghe; Patrick Vermersch
Vocal cord and diaphragm paralysis, as clinical features of a French family with autosomal recessive Charcot-Marie-Tooth disease, associated with a new mutation in the GDAP1 gene.
Neuromuscular disorders : NMD 2004;14(4):261-4.
2004: A Lacour; Jérôme de Seze; Eugeniu Revenco; Christine Lebrun; K Masmoudi; Elisabeth Vidry; Lucien Rumbach; M Chatel; A Verier; Patrick Vermersch
Acute aphasia in multiple sclerosis: A multicenter study of 22 patients.
Neurology 2004;62(6):974-7.
2004: Hélène Zephir; Jérôme de Seze; A Duhamel; Marc Debouverie; P Hautecoeur; Christine Lebrun; Irina Malikova; J Pelletier; O Sénéchal; Patrick Vermersch
Treatment of progressive forms of multiple sclerosis by cyclophosphamide: a cohort study of 490 patients.
Journal of the neurological sciences 2004;218(1-2):73-7.
2004: Jérôme de Seze; Sylvain Dubucquoi; Anne-Laure Fauchais; Eric Hachulla; Torsten Matthias; Didier Lefranc; Pierre-Yves Hatron; Patrick Vermersch; Torsten Witte
Autoantibodies against alpha-fodrin in Sjögren's syndrome with neurological manifestations.
The Journal of rheumatology 2004;31(3):500-3.
2004: Patrick Vermersch
[Are there arguments for initiating an etiological treatment at the onset of the first demyelinating episode?].
Presse médicale (Paris, France : 1983) 2004;33(3):180-6; discussion 192.
2004: Brigitte Delisse; Jérôme de Seze; A Mackowiak; J B N'Kendjuo; A Verier; O Derepeer; C Boisselier; P Devos; P Hautecoeur; Patrick Vermersch
Therapy related acute myeloblastic leukaemia after mitoxantrone treatment in a patient with multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(1):92.
2004: Kathy Dujardin; Pascal Sockeel; Marilyn Cabaret; J De Sèze; Patrick Vermersch
[BCcogSEP: a French test battery evaluating cognitive functions in multiple sclerosis].
Revue neurologique 2004;160(1):51-62.
2004: Didier Lefranc; Lionel Almeras; Sylvain Dubucquoi; Jérôme de Seze; Patrick Vermersch; Lionel Prin
Distortion of the self-reactive IgG antibody repertoire in multiple sclerosis as a new diagnostic tool.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(1):669-78.
2003: Charlotte Cordonnier; Jérôme de Seze; G Breteau; Didier Ferriby; Emmanuel Michelin; Tanya Stojkovic; Jean-Pierre Pruvo; Patrick Vermersch
Prospective study of patients presenting with acute partial transverse myelopathy.
Journal of neurology 2003;250(12):1447-52.
2003: Jérôme de Seze; Christine Lebrun; Tanya Stojkovic; Didier Ferriby; M Chatel; Patrick Vermersch
Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2003;9(5):521-5.
2003: Tanya Stojkovic; Jérôme de Seze; O Dubourg; M C Arne-Bes; S Tardieu; Jean-Claude Hache; Patrick Vermersch
Autonomic and respiratory dysfunction in Charcot-Marie-Tooth disease due to Thr124Met mutation in the myelin protein zero gene.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2003;114(9):1609-14.
2003: Jérôme de Seze; Sylvain Dubucquoi; Anne-Laure Fauchais; Torsten Matthias; David Devos; Giovanni Castelnovo; Tanya Stojkovic; Didier Ferriby; Eric Hachulla; Pierre Labauge; Didier Lefranc; Pierre-Yves Hatron; Patrick Vermersch; Torsten Witte
Alpha-fodrin autoantibodies in the differential diagnosis of MS and Sjögren syndrome.
Neurology 2003;61(2):268-9.
2003: Hélène Zephir; Jérôme de Seze; Tanya Stojkovic; Brigitte Delisse; Didier Ferriby; Marilyn Cabaret; Patrick Vermersch
Multiple sclerosis and depression: influence of interferon beta therapy.
Multiple sclerosis (Houndmills, Basingstoke, England) 2003;9(3):284-8.
2003: Tanya Stojkovic; Jérôme de Seze; Jean-François Hurtevent; François Fourrier; Patrick Vermersch
Phrenic nerve palsy as a feature of chronic inflammatory demyelinating polyradiculoneuropathy.
Muscle & nerve 2003;27(4):497-9.
2003: A Kreisler; Jérôme de Seze; Tanya Stojkovic; Brigitte Delisse; M Combelles; A Vérier; P Hautecoeur; Patrick Vermersch
Multiple sclerosis, interferon beta and clinical thyroid dysfunction.
Acta neurologica Scandinavica 2003;107(2):154-7.
2003: Tanya Stojkovic; Jérôme de Seze; Jean-François Hurtevent; P Lestavel; Patrick Vermersch
[Hypertrophy of the biceps surae after post-radiation lumbar radiculopathy].
Revue neurologique 2003;159(1):83-6.
2002: Sophie Delalande; Jérôme de Seze; Didier Ferriby; Tanya Stojkovic; Patrick Vermersch
[Late onset multiple sclerosis].
Revue neurologique 2002;158(11):1082-7.
2002: Patrick Vermersch; Jérôme de Seze; Brigitte Delisse; S Lemaire; Tanya Stojkovic
Quality of life in multiple sclerosis: influence of interferon-beta1 a (Avonex) treatment.
Multiple sclerosis (Houndmills, Basingstoke, England) 2002;8(5):377-81.
2002: Hélène Zephir; Jérôme de Seze; Didier Ferriby; Tanya Stojkovic; Patrick Vermersch
[Epstein-Barr meningoencephaloradiculitis in a immunocompetent woman].
Revue neurologique 2002;158(8-9):830-2.
2002: Sylvain Dubucquoi; Jérôme de Seze; Didier Lefranc; Lionel Almeras; Virginie Dutoit; Lionel Prin; Patrick Vermersch
Interferon beta in multiple sclerosis: relationship between sustained serum IgG levels and clinical outcome.
Journal of neuroimmunology 2002;129(1-2):232.
2002: Sophie Delalande; Tanya Stojkovic; C Rose; Alain Millaire; Jean-François Hurtevent; Patrick Vermersch
[Bilateral phrenic nerve paralysis, dysautonomia and restrictive cardiomyopathy in a case of POEMS syndrome].
Revue neurologique 2002;158(6-7):737-40.
2002: Jérôme de Seze; Tanya Stojkovic; Didier Ferriby; Jean-Yves Gauvrit; C Montagne; F Mounier-Vehier; A Verier; Jean-Pierre Pruvo; Jean-Claude Hache; Patrick Vermersch
Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile.
Journal of the neurological sciences 2002;197(1-2):57-61.
2002: Jérôme de Seze; Katell Peoc'h; Didier Ferriby; Tanya Stojkovic; Jean-Louis Laplanche; Patrick Vermersch
14-3-3 Protein in the cerebrospinal fluid of patients with acute transverse myelitis and multiple sclerosis.
Journal of neurology 2002;249(5):626-7.
2002: Lionel Almeras; Bertrand Meresse; Jérôme Seze; D De Lefranc; Sylvain Dubucquoi; Isabelle Fajardy; Patrick Vermersch; Lionel Prin
Interleukin-10 promoter polymorphism in multiple sclerosis: association with disease progression.
European cytokine network 2002;13(2):200-6.
2002: Didier Ferriby; Tanya Stojkovic; Jérôme de Seze; Jean-François Hurtevent; Patrick Vermersch
[Chronic polyradiculoneuritis disclosing sarcoidosis].
Revue neurologique 2002;158(3):357-60.
2002: Jérôme de Seze; A Mackowiak; Tanya Stojkovic; Didier Ferriby; P Hautecoeur; Patrick Vermersch
[Primary progressive forms of multiple sclerosis: application of the new diagnostic criteria in French].
Revue neurologique 2002;158(3):341-5.
2002: Patrick Vermersch; Jérôme de Seze; Tanya Stojkovic; P Hautecoeur
Interferon beta1a (Avonex) treatment in multiple sclerosis: similarity of effect on progression of disability in patients with mild and moderate disability.
Journal of neurology 2002;249(2):184-7.
2002: Hélène Zephir; Jérôme de Seze; O Sénéchal; Tanya Stojkovic; Didier Ferriby; B Deliss; B Dubus; A Verier; P Hautecoeur; Patrick Vermersch
[Treatment of progressive multiple sclerosis with cyclophosphamide].
Revue neurologique 2002;158(1):65-9.
2001: Jérôme de Seze; David Devos; Giovanni Castelnovo; Pierre Labauge; Sylvain Dubucquoi; Tanya Stojkovic; Didier Ferriby; Patrick Vermersch
The prevalence of Sjögren syndrome in patients with primary progressive multiple sclerosis.
Neurology 2001;57(8):1359-63.
2001: Hélène Zephir; Tanya Stojkovic; Claude-Alain Maurage; Jean-François Hurtevent; Patrick Vermersch
[Tubular aggregate congenital myopathy associated with neuromuscular block].
Revue neurologique 2001;157(10):1293-6.
2001: Nicolas Sergeant; Bernard Sablonnière; Susanna Schraen-Maschke; Antoine Ghestem; Claude-Alain Maurage; Annick Wattez; Patrick Vermersch; André Delacourte
Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1.
Human molecular genetics 2001;10(19):2143-55.
2001: Didier Ferriby; Jérôme de Seze; Tanya Stojkovic; E Hachulla; B Wallaert; Alain Destée; P Y Hatron; Patrick Vermersch
Long-term follow-up of neurosarcoidosis.
Neurology 2001;57(5):927-9.
2001: Patrick Vermersch; J P Marissal
[Medical-social aspects of multiple sclerosis].
Revue neurologique 2001;157(8-9 Pt 2):1163-8.
2001: Yann Mikaeloff; Thibault Moreau; Marc Debouverie; J Pelletier; Christine Lebrun; Olivier Gout; Jean-Michel Pedespan; C Van Hulle; Patrick Vermersch; Gérard Ponsot
Interferon-beta treatment in patients with childhood-onset multiple sclerosis.
The Journal of pediatrics 2001;139(3):443-6.
2001: Tanya Stojkovic; Claude-Alain Maurage; A Moerman; Jean-François Hurtevent; R Krivosic-Horber; J F Pellissier; Patrick Vermersch
Congenital myopathy with central cores and fingerprint bodies in association with malignant hyperthermia susceptibility.
Neuromuscular disorders : NMD 2001;11(6-7):538-41.
2001: Jérôme de Seze; Tanya Stojkovic; G Breteau; Christian Lucas; U Michon-Pasturel; Jean-Yves Gauvrit; E Hachulla; F Mounier-Vehier; Jean-Pierre Pruvo; Didier LEYS; Alain Destée; P Y Hatron; Patrick Vermersch
Acute myelopathies: Clinical, laboratory and outcome profiles in 79 cases.
Brain : a journal of neurology 2001;124(Pt 8):1509-21.
2001: Jérôme de Seze; Carl F Arndt; Tanya Stojkovic; M Ayachi; Jean-Yves Gauvrit; M Bughin; T Saint Michel; Jean-Pierre Pruvo; Jean-Claude Hache; Patrick Vermersch
Pupillary disturbances in multiple sclerosis: correlation with MRI findings.
Journal of the neurological sciences 2001;188(1-2):37-41.
2001: Jérôme de Seze; Sylvain Dubucquoi; Didier Lefranc; F Virecoulon; I Nuez; Virginie Dutoit; Patrick Vermersch; Lionel Prin
IgG reactivity against citrullinated myelin basic protein in multiple sclerosis.
Journal of neuroimmunology 2001;117(1-2):149-55.
2001: Jérôme de Seze; Tanya Stojkovic; E Hachulla; G Breteau; U Michon-Pasturel; F Mounier-Vehier; P Y Hatron; Patrick Vermersch
[Myelopathy - Sjogren's syndrome association: analysis of clinical and radiological findings and clinical course].
Revue neurologique 2001;157(6-7):669-78.
2001: Didier Lefranc; Sylvain Dubucquoi; Lionel Almeras; Jérôme de Seze; B Tourvieille; Patricia Dussart; J P Aubert; Patrick Vermersch; Lionel Prin
Molecular analysis of endogenous retrovirus HRES-1: identification of frameshift mutations in region encoding putative 28-kDa autoantigen.
Biochemical and biophysical research communications 2001;283(2):437-44.
2001: Marie-Anne Mackowiak-Cordoliani; Jérôme de Seze; Tanya Stojkovic; Didier Ferriby; D Ingrand; Patrick Vermersch
[Sarcoidosis and progressive multifocal leukoencephalopathy].
Revue neurologique 2001;157(5):547-50.
2001: Tanya Stojkovic; MF Verdin; Jean-François Hurtevent; E Laureau; R Krivosic-Horber; Patrick Vermersch
Guillain-Barré syndrome resembling brainstem death in a patient with brain injury.
Journal of neurology 2001;248(5):430-2.
2001: Jérôme de Seze; Tanya Stojkovic; Jean-Yves Gauvrit; David Devos; M Ayachi; François Cassim; T Saint Michel; Jean-Pierre Pruvo; Jean-Daniel Guieu; Patrick Vermersch
Autonomic dysfunction in multiple sclerosis: cervical spinal cord atrophy correlates.
Journal of neurology 2001;248(4):297-303.
2000: Tanya Stojkovic; Jérôme de Seze; Jean-François Hurtevent; Carl F Arndt; A Beaume; Jean-Claude Hache; Patrick Vermersch
Visual evoked potentials study in chronic idiopathic inflammatory demyelinating polyneuropathy.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2000;111(12):2285-91.
2000: Tanya Stojkovic; J de Seze; C A Maurage; C Rose; Jean-Claude Hache; Patrick Vermersch
Atypical form of non-Langerhans histiocytosis with disseminated brain and leptomeningeal lesions.
Journal of neurology, neurosurgery, and psychiatry 2000;69(5):675-8.
2000: G Breteau; Tanya Stojkovic; Jérôme de Seze; Jean-Yves Gauvrit; Jean-Pierre Pruvo; Patrick Vermersch
[Adenovirus myelitis and Epstein-Barr myelitis: two unusual viral causes with similar presentations].
Revue neurologique 2000;156(8-9):786-9.
2000: Jérôme de Seze; Tanya Stojkovic; Jean-Yves Gauvrit; T Saint Michel; M Ayachi; Jean-Pierre Pruvo; Patrick Vermersch
Cardiac repolarization abnormalities in multiple sclerosis: spinal cord MRI correlates.
Muscle & nerve 2000;23(8):1284-6.
2000: X Douay; Jérôme de Seze; Tanya Stojkovic; Jean-Yves Gauvrit; C Savage; Jean-Pierre Pruvo; Patrick Vermersch
[Paraplegia episodes revealing tuberculous myelitis].
Revue neurologique 2000;156(6-7):661-4.
2000: Jérôme de Seze; M Ayachi; Tanya Stojkovic; Jean-Yves Gauvrit; T Saint Michel; Jean-Pierre Pruvo; Patrick Vermersch
[Spinal cord magnetic resonance imaging in multiple sclerosis: importance of determining degree of atrophy as a marker of disease course].
Revue neurologique 2000;156(5):491-6.
1999: Jérôme de Seze; C Lucas; X Leclerc; A Sahli; Patrick Vermersch; D Leys
One-and-a-half syndrome in pontine infarcts: MRI correlates.
Neuroradiology 1999;41(9):666-9.
1999: André Delacourte; Jean-Philippe David; Nicolas Sergeant; Luc BUEE; Annick Wattez; Patrick Vermersch; F Ghozali; C Fallet-Bianco; Florence Pasquier; Florence Lebert; H Petit; C Di Menza
The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.
Neurology 1999;52(6):1158-65.
1999: Jérôme de Seze; B Udd; Patrick Vermersch
[Tibial muscular dystrophy. A rare form of distal myopathy].
Revue neurologique 1999;155(4):296-305.
1999: Tanya Stojkovic; Philippe Latour; Antoon Vandenberghe; Jean-François Hurtevent; Patrick Vermersch
Sensorineural deafness in X-linked Charcot-Marie-Tooth disease with connexin 32 mutation (R142Q)
Neurology 1999;52(5):1010-4.
1999: A Mackowiak; Tanya Stojkovic; Jean-François Hurtevent; Claude-Alain Maurage; Patrick Vermersch
[Late onset of type I familial amyloid neuropathy: results of biopsy from accessory salivary glands].
Revue neurologique 1999;155(2):155-7.
1998: Jérôme de Seze; Bjarne Udd; Henna Haravuori; Bernard Sablonnière; Claude-Alain Maurage; Jean-François Hurtevent; N Boutry; Tanya Stojkovic; S Schraen; H Petit; Patrick Vermersch
The first European family with tibial muscular dystrophy outside the Finnish population.
Neurology 1998;51(6):1746-8.
1998: P Krystkowiak; Patrick Vermersch; C A Maurage; H Petit
[Collet-Sicard syndrome disclosing periarteritis nodosa].
Revue neurologique 1998;154(11):777-9.
1998: Isabelle Vuillaume; Patrick Vermersch; Alain Destée; H Petit; Bernard Sablonnière
Genetic polymorphisms adjacent to the CAG repeat influence clinical features at onset in Huntington's disease.
Journal of neurology, neurosurgery, and psychiatry 1998;64(6):758-62.
1998: P Charpentier; Patrick Vermersch; M Ayachi; H Petit
A localized postoperative cervical syrinx revealed by orthostatic hypotension.
European neurology 1998;39(4):250-1.
1997: P Krystkowiak; Patrick Vermersch; Gilles Beaucaire; H Petit
[Regressive leukoencephalopathy in chronic brucellosis].
Revue neurologique 1997;153(12):781-4.
1997: Nicolas Sergeant; Jean-Philippe David; Didier Lefranc; Patrick Vermersch; Annick Wattez; André Delacourte
Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases.
FEBS letters 1997;412(3):578-82.
1997: Nicolas Sergeant; Jean-Philippe David; Michel Goedert; R Jakes; Patrick Vermersch; Luc BUEE; Didier Lefranc; Annick Wattez; André Delacourte
Two-dimensional characterization of paired helical filament-tau from Alzheimer's disease: demonstration of an additional 74-kDa component and age-related biochemical modifications.
Journal of neurochemistry 1997;69(2):834-44.
1996: Patrick Vermersch; Nicolas Sergeant; M M Ruchoux; H Hofmann-Radvanyi; Annick Wattez; H Petit; P Dwailly; André Delacourte
Specific tau variants in the brains of patients with myotonic dystrophy.
Neurology 1996;47(3):711-7.
1996: Didier Lefranc; Patrick Vermersch; J Dallongeville; C Daems-Monpeurt; H Petit; André Delacourte
Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease.
Neuroscience letters 1996;212(2):91-4.
1996: Patrick Vermersch; J Roche; M Hamon; C Daems-Monpeurt; J P Pruvo; P Dewailly; H Petit
White matter magnetic resonance imaging hyperintensity in Alzheimer's disease: correlations with corpus callosum atrophy.
Journal of neurology 1996;243(3):231-4.
1996: V Buée Scherrer; Patrick R Hof; Luc BUEE; B Leveugle; Patrick Vermersch; Daniel P Perl; C Warren Olanow; André Delacourte
Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease.
Acta neuropathologica 1996;91(4):351-9.
1995: Nicolas Sergeant; Thierry Bussière; Patrick Vermersch; J P Lejeune; André Delacourte
Isoelectric point differentiates PHF-tau from biopsy-derived human brain tau proteins.
Neuroreport 1995;6(16):2217-20.
1995: Patrick Vermersch; Jean-Philippe David; B Frigard; C Fallet-Bianco; Annick Wattez; H Petit; André Delacourte
Cortical mapping of Alzheimer pathology in brains of aged non-demented subjects.
Progress in neuro-psychopharmacology & biological psychiatry 1995;19(6):1035-47.
1994: Patrick Vermersch; Y Robitaille; L Bernier; Annick Wattez; D Gauvreau; André Delacourte
Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: evidence for general cortical involvement.
Acta neuropathologica 1994;87(6):572-7.
1994: Patrick Vermersch; C Daems-Monpeurt; M Parent; J P Pruvo; André Delacourte; H Petit
[Subcortical dementia of the Neumann type. Contribution of diagnostic imaging].
Revue neurologique 1994;150(5):354-8.
1993: Patrick Vermersch; André Delacourte; France Javoy-Agid; JEAN-JACQUES HAUW; Yves Agid
Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteins.
Annals of neurology 1993;33(5):445-50.
1993: Patrick Vermersch; P E Sautière; M Goudemand; André Delacourte
General cortical involvement in a late-onset case of Alzheimer disease. A biochemical approach by quantitation of abnormal tau proteins.
Molecular and chemical neuropathology / sponsored by the International Society for Neurochemistry and the World Federation of Neurology and research groups on neurochemistry and cerebrospinal fluid 1993;18(3):213-24.
1992: Patrick Vermersch; B Frigard; Jean-Philippe David; C Fallet-Bianco; André Delacourte
Presence of abnormally phosphorylated Tau proteins in the entorhinal cortex of aged non-demented subjects.
Neuroscience letters 1992;144(1-2):143-6.
1992: Patrick Vermersch; Jean-François Hurtevent; Florence Pasquier; J F Catanzariti; H Petit
[Stiff-Man syndrome with late onset].
Revue neurologique 1992;148(5):350-4.
1992: Patrick Vermersch; B Frigard; André Delacourte
Mapping of neurofibrillary degeneration in Alzheimer's disease: evaluation of heterogeneity using the quantification of abnormal tau proteins.
Acta neuropathologica 1992;85(1):48-54.
1990: Alain Destée; J P Muller; Patrick Vermersch; J P Pruvo; P Warot
[Hemiballismus. Hemichorea. Striatal infarction].
Revue neurologique 1990;146(2):150-2.